UA75072C2 - Solid oral pharmaceutical composition comprising bisphosphonic acid derivative and process for preparing this composition - Google Patents

Solid oral pharmaceutical composition comprising bisphosphonic acid derivative and process for preparing this composition Download PDF

Info

Publication number
UA75072C2
UA75072C2 UA2002118915A UA2002118915A UA75072C2 UA 75072 C2 UA75072 C2 UA 75072C2 UA 2002118915 A UA2002118915 A UA 2002118915A UA 2002118915 A UA2002118915 A UA 2002118915A UA 75072 C2 UA75072 C2 UA 75072C2
Authority
UA
Ukraine
Prior art keywords
item
derivative
bisphosphonic acid
composition
solid oral
Prior art date
Application number
UA2002118915A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Inst Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Farmaceutyczny filed Critical Inst Farmaceutyczny
Publication of UA75072C2 publication Critical patent/UA75072C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UA2002118915A 2000-05-11 2001-10-05 Solid oral pharmaceutical composition comprising bisphosphonic acid derivative and process for preparing this composition UA75072C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL340087A PL196485B1 (pl) 2000-05-11 2000-05-11 Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
PCT/PL2001/000039 WO2001085176A1 (en) 2000-05-11 2001-05-10 The solid oral pharmaceutical composition comprising a bisphosphonic acid derivative

Publications (1)

Publication Number Publication Date
UA75072C2 true UA75072C2 (en) 2006-03-15

Family

ID=20076600

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002118915A UA75072C2 (en) 2000-05-11 2001-10-05 Solid oral pharmaceutical composition comprising bisphosphonic acid derivative and process for preparing this composition

Country Status (6)

Country Link
CZ (1) CZ301047B6 (cs)
PL (1) PL196485B1 (cs)
RU (1) RU2288705C2 (cs)
SK (1) SK287298B6 (cs)
UA (1) UA75072C2 (cs)
WO (1) WO2001085176A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1004331B (el) * 2002-10-07 2003-09-05 Verisfield (Uk) Ltd Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
CA2540488A1 (en) * 2003-09-29 2005-04-07 Cipla Limited Pharmaceutical formulation with improved stability
WO2006046100A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Pharmaceutical composition of alendronic acid
GB0616794D0 (en) * 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
WO2009018834A1 (en) * 2007-08-06 2009-02-12 Pharmathen S.A. Pharmaceutical composition containing bisphosphonate and method for the preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
FI89364C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya, farmakologiskt anvaendbara metylenbisfosfonsyraderivat
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
CA2136818C (en) * 1992-05-29 2000-01-18 Susan M. Kaas Sulfur-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
WO1993024500A1 (en) * 1992-05-29 1993-12-09 The Procter & Gamble Pharmaceuticals, Inc. Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
BR9916850A (pt) * 1998-12-23 2001-10-16 Jomaa Pharmaka Gmbh Uso de bisfosfonatos para a profilaxia e tratamento de processos infecciosos
CZ20004762A3 (cs) * 1999-06-24 2001-04-11 Hassan Jomaa Bisfosfonové kyseliny a jejich deriváty obsahující léčiva pro profylaxi a ošetřování autoimunitních chorob i alergií

Also Published As

Publication number Publication date
CZ301047B6 (cs) 2009-10-21
WO2001085176A1 (en) 2001-11-15
SK15842002A3 (sk) 2003-03-04
RU2288705C2 (ru) 2006-12-10
PL340087A1 (en) 2001-11-19
CZ20023700A3 (cs) 2003-04-16
SK287298B6 (sk) 2010-06-07
PL196485B1 (pl) 2008-01-31

Similar Documents

Publication Publication Date Title
CN102056589B (zh) 包含bibw 2992的固体药物制剂
JP4471498B2 (ja) ジホスホン酸を含有する組成物
PT2063868E (pt) Composições farmacêuticas contendo rosuvastatina de cálcio
KR100694550B1 (ko) 고용량의 이반드로네이트 제형물
KR20080031037A (ko) 결합형 에스트로겐과 바제독시펜의 제형
CN111278431A (zh) 普利多匹定的高浓度剂型
JP2002326927A (ja) 塩酸メトホルミン含有速放性錠剤
US7198802B2 (en) Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient
JP2016117738A (ja) シロドシン−シクロデキストリン包接化合物
KR101617054B1 (ko) 고형내복제제
UA75072C2 (en) Solid oral pharmaceutical composition comprising bisphosphonic acid derivative and process for preparing this composition
WO2011104588A2 (en) Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
JPH0774154B2 (ja) イブプロフェンリシネート医薬製剤
JP7336528B2 (ja) ネフォパムおよびアセトアミノフェンを含む薬学的組成物の製造方法、およびそれによって得られる薬学的組成物
AP858A (en) Process for preparing solid dosage forms of very low-dose drugs.
JP3919840B2 (ja) 医薬組成物
US20180280322A1 (en) Stable formulations of fingolimod
KR101379664B1 (ko) 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물
KR20160140567A (ko) 오셀타미비어 유리염기를 포함하는 약학 조성물
KR20250049977A (ko) 개선된 안정성의 셀레콕시브 - 아세트아미노펜 조합 및 이를 제조하는 방법
EP1491199A1 (en) Pharmaceutical compositions of alendronate sodium trihydrate and process for the preparation thereof